Twi Biotechnology, Inc.

I-Yin Lin, Iii

Chih-Kuang Chen

Wei-Shu Lu

Mannching Sherry Ku

Chih-Ming Chen

Po-Yuan Tseng

Chen-En Tsai

Carl Oscar Brown, Iii

Danchen Gao

Carol Oscar Brown, Iii

A method for preventing or treating immunoinflammatory dermal disorders is provided. Also provided is a pharmaceutical composition for preventing or treating immunoinflammatory dermal disorders.

Methods and pharmaceutical compositions for preventing or treating immunoinflammatory dermal disorders

Uses of pharmaceutical compositions comprising berberine for treatment of dermatologic toxicities and other skin disorders.

Therapeutic uses of berberine formulations

Methods and compositions for treating and/or preventing hyperuricemia or metabolic disorders associated with hyperuricemia comprising administering to a patient in need a therapeutically effective amount of diacerein, rhein, or a pharmaceutically acceptable salt, an analog, a prodrug, or an active metabolite thereof.

Methods and compositions for treating hyperuricemia and metabolic disorders associated with hyperuricemia

Methods for treating abnormal glycosylated hemoglobin (HbA1c) levels in a patient in need thereof, wherein the provided methods comprise administering to a patient in need a therapeutically effective amount of an Interleukin-1&#x3b2; modulator. Also, the invention provides compositions comprising at least one lipid modifying agent and an IL-1&#x3b2; modulator.

Methods of decreasing glycosylated hemoglobin in patients with dyslipidemia

The present invention provides methods of treating type II diabetes using combinations of diacerein or its derivatives with other antidiabetic agents. The methods may also allow improving glycemic control of type II diabetes patients and/or reducing side effects and/or cardiovascular risks of antidiabetic agents.

Growing community of inventors

Taipei, Taiwan

I-Yin Lin, Iii